Franco EL - Search Results

1

Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction.

Covert C, Ding L, Brown D, Franco EL, Bernstein DI, Kahn JA. Covert C, et al. Among authors: franco el. Hum Vaccin Immunother. 2019;15(7-8):1962-1969. doi: 10.1080/21645515.2018.1564438. Epub 2019 Feb 20. Hum Vaccin Immunother. 2019. PMID: 30633598 Free PMC article.

2

Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.

Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, Rohan TE. Franco EL, et al. J Infect Dis. 1999 Nov;180(5):1415-23. doi: 10.1086/315086. J Infect Dis. 1999. PMID: 10515798

3

Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students.

Richardson H, Franco E, Pintos J, Bergeron J, Arella M, Tellier P. Richardson H, et al. Sex Transm Dis. 2000 Feb;27(2):79-86. doi: 10.1097/00007435-200002000-00005. Sex Transm Dis. 2000. PMID: 10676974

4

Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada.

Pintos J, Black MJ, Sadeghi N, Ghadirian P, Zeitouni AG, Viscidi RP, Herrero R, Coutlée F, Franco EL. Pintos J, et al. Among authors: franco el. Oral Oncol. 2008 Mar;44(3):242-50. doi: 10.1016/j.oraloncology.2007.02.005. Epub 2007 Apr 27. Oral Oncol. 2008. PMID: 17467327

5

Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination.

Franco EL, Ferenczy A. Franco EL, et al. Future Oncol. 2007 Jun;3(3):319-27. doi: 10.2217/14796694.3.3.319. Future Oncol. 2007. PMID: 17547527 Review.

6

Prophylactic human papillomavirus vaccines: potential for sea change.

Ferenczy A, Franco EL. Ferenczy A, et al. Among authors: franco el. Expert Rev Vaccines. 2007 Aug;6(4):511-25. doi: 10.1586/14760584.6.4.511. Expert Rev Vaccines. 2007. PMID: 17669006 Free article. Review.

7

Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.

Trottier H, Mahmud S, Prado JC, Sobrinho JS, Costa MC, Rohan TE, Villa LL, Franco EL. Trottier H, et al. Among authors: franco el. J Infect Dis. 2008 May 15;197(10):1436-47. doi: 10.1086/587698. J Infect Dis. 2008. PMID: 18419547 Free PMC article.

8

Cervical cancer screening following prophylactic human papillomavirus vaccination.

Franco EL, Cuzick J. Franco EL, et al. Vaccine. 2008 Mar 14;26 Suppl 1:A16-23. doi: 10.1016/j.vaccine.2007.11.069. Vaccine. 2008. PMID: 18642468 Review.

9

Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.

Franco EL, Tsu V, Herrero R, Lazcano-Ponce E, Hildesheim A, Muñoz N, Murillo R, Sánchez GI, Andrus JK. Franco EL, et al. Vaccine. 2008 Aug 19;26 Suppl 11:L88-95. doi: 10.1016/j.vaccine.2008.05.026. Vaccine. 2008. PMID: 18945406 Review.

10

Influence of partner's infection status on prevalent human papillomavirus among persons with a new sex partner.

Burchell AN, Tellier PP, Hanley J, Coutlée F, Franco EL. Burchell AN, et al. Among authors: franco el. Sex Transm Dis. 2010 Jan;37(1):34-40. doi: 10.1097/OLQ.0b013e3181b35693. Sex Transm Dis. 2010. PMID: 19704391 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters